Scarica l'app Stockscreener
79.33
0.62%
0.49
Pre-mercato:
78.93
-0.40
-0.50%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CVS Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$78.84
Aprire:
$78.98
Volume 24 ore:
6.86M
Relative Volume:
0.78
Capitalizzazione di mercato:
$101.67B
Reddito:
$402.11B
Utile/perdita netta:
$1.73B
Rapporto P/E:
57.34
EPS:
1.3835
Flusso di cassa netto:
$7.81B
1 W Prestazione:
+7.95%
1M Prestazione:
+3.94%
6M Prestazione:
+1.84%
1 anno Prestazione:
+15.02%
Intervallo 1D:
$78.44
$79.46
Intervallo di 1 settimana:
$72.10
$79.56
Portata 52W:
$58.35
$85.15
Cvs Health Corp Stock (CVS) Company Profile
Nome
Cvs Health Corp
Settore
Industria
Telefono
(401) 765-1500
Indirizzo
ONE CVS DR., WOONSOCKET
Compare CVS vs UNH, CI, ELV, HUM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
79.33 | 101.67B | 402.11B | 1.73B | 7.81B | 1.3835 |
UNH
Unitedhealth Group Inc
|
304.33 | 276.23B | 447.57B | 12.81B | 16.08B | 13.19 |
CI
Cigna Group
|
271.25 | 71.52B | 274.88B | 6.29B | 8.39B | 22.19 |
ELV
Elevance Health Inc
|
311.53 | 68.43B | 199.13B | 5.66B | 3.17B | 25.11 |
HUM
Humana Inc
|
192.15 | 23.07B | 129.66B | 1.20B | 375.00M | 9.8083 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-12 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2025-10-14 | Iniziato | Goldman | Buy |
| 2025-08-18 | Aggiornamento | UBS | Neutral → Buy |
| 2025-08-14 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | Aggiornamento | Edward Jones | Hold → Buy |
| 2024-12-03 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-05-30 | Iniziato | Robert W. Baird | Neutral |
| 2024-05-07 | Downgrade | TD Cowen | Buy → Hold |
| 2024-05-02 | Downgrade | UBS | Buy → Neutral |
| 2024-05-01 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2023-12-22 | Iniziato | HSBC Securities | Buy |
| 2023-09-19 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Downgrade | Edward Jones | Buy → Hold |
| 2023-05-26 | Iniziato | Piper Sandler | Overweight |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Ripresa | Morgan Stanley | Overweight |
| 2022-06-17 | Iniziato | Loop Capital | Buy |
| 2022-05-27 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Iniziato | Goldman | Buy |
| 2021-12-01 | Iniziato | Seaport Research Partners | Buy |
| 2021-05-19 | Iniziato | Wells Fargo | Equal Weight |
| 2021-03-17 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-01-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-09-17 | Iniziato | Piper Sandler | Overweight |
| 2020-07-01 | Iniziato | SVB Leerink | Mkt Perform |
| 2020-05-14 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Ripresa | RBC Capital Mkts | Outperform |
| 2019-09-12 | Iniziato | Deutsche Bank | Buy |
| 2019-06-05 | Aggiornamento | Standpoint Research | Hold → Buy |
| 2019-04-29 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Iniziato | Guggenheim | Buy |
| 2019-04-15 | Downgrade | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Reiterato | BofA/Merrill | Buy |
| 2019-03-13 | Iniziato | Bernstein | Outperform |
| 2019-02-20 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Iniziato | UBS | Buy |
| 2018-12-18 | Iniziato | Barclays | Overweight |
| 2018-11-29 | Ripresa | Goldman | Neutral |
| 2018-11-28 | Iniziato | Evercore ISI | Outperform |
| 2018-10-26 | Ripresa | Wolfe Research | Peer Perform |
| 2018-07-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2018-02-27 | Ripresa | BofA/Merrill | Buy |
| 2018-02-13 | Reiterato | Citigroup | Neutral |
Mostra tutto
Cvs Health Corp Borsa (CVS) Ultime notizie
Huge News for CVS Stock Investors - The Globe and Mail
Huge News for CVS Stock Investors - The Motley Fool
CVS Health Corporation (CVS): Legal Clarity and Core Strengths Support the Bull Case - Insider Monkey
Robeco Institutional Asset Management B.V. Raises Position in CVS Health Corporation $CVS - MarketBeat
Burney Co. Trims Stake in CVS Health - National Today
Carnegie Investment Counsel Purchases New Shares in CVS Health Corporation $CVS - MarketBeat
Trump Administration Walks Back Key Claims in New York Health Fraud Case: ReportCVS Health (NYSE:CVS) - Benzinga
Coerente Capital Management Trims CVS Health Stock Position - National Today
Cantor Fitzgerald Investment Advisors L.P. Has $29.68 Million Stock Holdings in CVS Health Corporation $CVS - MarketBeat
Coerente Capital Management Trims Stock Position in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Sold by Factory Mutual Insurance Co. - MarketBeat
CVS Stock Quote Price and Forecast - CNN
CVS Health Tops Daily Volume Chart as Medicare Boost and Institutional Buying Surge Past $540 Million - Bitget
CVS Health Corp. stock (US1266501006): Is its pharmacy-retail model strong enough to unlock new upsi - AD HOC NEWS
How CVS Health Supports Better Heart Health - ACCESS Newswire
Douglas Lane & Associates LLC Cuts Holdings in CVS Health Corporation $CVS - MarketBeat
Flagship Capital Management Inc. Invests $2.16 Million in CVS Health Corporation $CVS - MarketBeat
Jim Cramer Says “CVS Is Real” - Insider Monkey
CVS Health, US Seek Tax-Refund Suit Stay Pending Deal Approval - Bloomberg Law News
Aetna Better Health® of Virginia opens new community resource center in Roanoke - CVS Health
Cantor Fitzgerald reiterates CVS Health stock Overweight rating at $95 - Investing.com
OFI Invest Asset Management Takes Position in CVS Health Corporation $CVS - MarketBeat
HIV, AIDS Patients End Disability Bias Suit With CVS - Law360
CVS Health Corporation $CVS Shares Sold by Yousif Capital Management LLC - MarketBeat
Mail Order Pharmacy Market to Get an Explosive Growth | CVS Health - openPR.com
Aetna Provider Survey Reveals Optimism and Opportunities to Simplify Health Care - CVS Health
Health insurers pare back some prior-approval requirements - Crain's Chicago Business
US Health Insurers Pare Back Some Prior-Approval Requirements - Bloomberg.com
Alignment Healthcare, Centene, CVS Health, Elevance Health, and Clover Health Stocks Trade Up, What You Need To Know - Yahoo Finance
Health insurers rise after US lifts 2027 Medicare Advantage payment rates - Reuters
Washington Blinked and Health Insurers Made $13 Billion - Yahoo Finance
CVS Health (NYSE:CVS) Shares Gap UpTime to Buy? - MarketBeat
CVS Health Stock Surges 7% on Positive Medicare Outlook as Turnaround Gains Momentum - International Business Times Australia
UnitedHealth, Humana, CVS Jump As CMS Boosts Medicare Payments - Benzinga
UnitedHealth, Alignment Healthcare, Humana And Other Big Stocks Moving Higher On Tuesday - Benzinga
CVS Stock Rises After CMS Medicare Advantage UpdateCVS Health (NYSE:CVS) - Benzinga
Cantor Fitzgerald reiterates CVS Health stock rating on MA margins - Investing.com
Inlet Private Wealth Reduces Stake in CVS Health - National Today
Daytona Street Capital LLC Invests $2.69 Million in CVS Health Corporation $CVS - MarketBeat
Trump Administration Finalizes 2.48% Medicare Advantage Payment Hike For 2027, Sending Insurer Stocks Surging - Benzinga
CVS Pharmacy: Essential Retail for Health and Wellness Needs - AD HOC NEWS
Humana shares surge 12% on 2027 Medicare rate boost; UNH, CVS rally - Investing.com
CVS, UnitedHealth, Humana, Elevance Shares Surge: Here's WhyUnitedHealth Group (NYSE:UNH) - Benzinga
US finalizes 2.48% Medicare Advantage payment hike; insurance stocks surge - Reuters
Medicare Finalizes 2.48% Rate Hike for Private Insurers in 2027 - Bloomberg.com
Check Your Medicine Cabinet for These Eye Drop Bottles After Millions Recalled - Gizmodo
May 6 webcast: CVS Health to detail first-quarter 2026 results - Stock Titan
SteelPeak Wealth LLC Trims Stake in CVS Health Corporation $CVS - MarketBeat
CVS Lawsuit And Antitrust Scrutiny Put PBM Economics Under The Microscope - Yahoo Finance
If You'd Invested $100 in CVS Health (CVS) Stock 5 Years Ago, Here's How Much You'd Have Today (Spoiler: You Wouldn't Have Lost Money) - AOL.com
CVS HEALTH Corp ($CVS) CEO 2025 Pay Revealed - Moomoo
Cvs Health Corp Azioni (CVS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.59%
0.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):